Physician profile
Hend Abulsayen
NPI 1558893743
$1,398.23
in general payments reported to CMS, 2019-2025
8 companies · $229 in 2025
The $229 reported for 2025 was less than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $53.44 · 2024: $1,115 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,120 · Travel and Lodging: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,120.48 |
| Travel and Lodging | $277.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $819.45 | 2023-2025 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Neurelis, INC. | $325.01 | 2023-2025 | Valtoco |
| Jazz Pharmaceuticals INC. | $143.57 | 2024 | |
| Azurity Pharmaceuticals, INC. | $34.48 | 2025 | Triptodur, Zonisade |
| Ucb, INC. | $21.09 | 2024 | Nayzilam |
| Sk Life Science, INC. | $19.92 | 2024 | |
| Otter Pharmaceuticals, LLC | $18.56 | 2025 | Sympazan |
| Acadia Pharmaceuticals INC | $16.15 | 2024 | Daybue |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hend Abulsayen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.